康妇炎胶囊联合甲硝唑及头孢曲松钠治疗湿热瘀结型慢性盆腔炎临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.33

基金项目:


Clinical Study on Kangfuyan Capsules Combined with Metronidazole and Ceftriaxone Sodium for Chronic Pelvic Inflammatory Disease with Dampness- Heat Accumulation Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察应用康妇炎胶囊联合甲硝唑及头孢曲松钠治疗湿热瘀结型慢性盆腔炎的效果。方法:选取 90 例湿热瘀结型慢性盆腔炎患者作为研究对象,按随机数字表法分为研究组和对照组各 45 例。2 组均予甲硝唑氯化钠注射液和注射用头孢曲松钠治疗,研究组加予康妇炎胶囊治疗。1 周为 1 个疗程,2 组均连续治疗 2 个疗程。统计 2 组治疗后的临床疗效及治疗期间不良反应的发生情况,观察治疗前后血清炎症因子[白细胞介素-1(IL-1)、白细胞介素-2(IL-2)、超敏 C-反应蛋白(hs-CRP)]的变化,比较 2 组治疗前及治疗 1、2 个疗程后的疼痛视觉模拟评分法 (VAS) 评分。结果:治疗 2 个疗程后,研究组总有效率为 97.78%,高于对照组的 82.22%,差异有统计学意义 (P<0.05)。2 组 IL-1、hs-CRP 水平均较治疗前降低,IL-2 水平均较治疗前升高,差异均有统计学意义(P<0.01);研究组 IL-1、hs-CRP 水平均低于对照组,IL-2 水平高于对照组,差异均有统计学意义 (P<0.01)。与同组治疗前比较,2 组治疗 1 个疗程及 2 个疗程的疼痛 VAS 评分均降低 (P<0.01)。与同组治疗 1 个疗程比较,2 组治疗 2 个疗程的疼痛 VAS 评分均降低 (P<0.01);研究组治疗 1 个疗程及 2 个疗程的疼痛 VAS 评分均低于对照组(P<0.01)。研究组不良反应发生率低于对照组,但差异无统计学意义 (P>0.05)。结论:康妇炎胶囊联合甲硝唑及头孢曲松钠治疗湿热瘀结型慢性盆腔炎患者临床疗效较好,可有效减轻机体的炎症反应与疼痛程度,安全性较好。

    Abstract:

    Abstract:Objective:To observe the effect of Kangfuyan capsules combined with metronidazole and ceftriaxone sodium for chronic pelvic inflammatory disease with dampness- heat accumulation syndrome. Methods: A total of 90 cases of patients with chronic pelvic inflammatory disease with dampness- heat accumulation syndrome were selected,and were divided into the study group and the control group according to the random number table method,45 cases in each group. Both groups were given metronidazole and sodium chloride injection and injection of ceftriaxone sodium,and the study group was additionally given Kangfuyan capsules. Both groups were continuously treated for two courses, one week being a course. The clinical effect after treatment and the incidence of adverse reactions during treatment were statistically analyzed in the two groups. Changes in inflammatory factors in serum, namely interleukin- 1(IL- 1), interleukin- 2(IL- 2), and hypersensitivity C-reactive protein(hs-CRP) before and after treatment were observed. Scores of Visual Analogue Scale(VAS) of pain before treatment as well as after one course and two courses were compared between the two groups. Results:After two courses,the total effective rate was 97.78% in the study group,higher than that of 82.22% in the control group,the difference being significant(P<0.05). The levels of IL-1 and hs-CRP in the two groups were decreased when compared with those before treatment,and the levels of IL-2 were increased,differences being significant(P<0.01);the levels of IL-1 and hs-CRP in the study group were lower than those in the control group,and the level of IL-2 was higher than that in the control group,differences being significant(P<0.01). Compared with those in the same group before treatment,scores of VAS of pain in the two groups were decreased after one course and two courses(P<0.01). Compared with those in the same group after one course, scores of VAS of pain in the two groups were decreased after two courses(P<0.01). After one course and two courses,scores of VAS of pain in the study group were lower than those in the control group(P<0.01). The incidence of adverse reactions in the study group was lower than that in the control group,but there was no significance being found in the difference(P>0.05). Conclusion:In the treatment of patients with chronic pelvic inflammatory disease with dampness- heat accumulation syndrome,the therapy of Kangfuyan capsules combined with metronidazole and ceftriaxone sodium has defined clinical effect,which can effectively relieve inflammatory response of body and pain with good safety.

    参考文献
    相似文献
    引证文献
引用本文

汤芝丽.康妇炎胶囊联合甲硝唑及头孢曲松钠治疗湿热瘀结型慢性盆腔炎临床研究[J].新中医,2021,53(7):64-68

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-04-08
  • 出版日期: